| 1 |
Challapalli S, Bonow RO, Gheorghiade M. Medical management of heart failure secondary to coronary artery disease. Coron Artery Dis 1998;9:659-74
DOI
PUBMED
ScienceOn
|
| 2 |
Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982;66:1146-9
DOI
PUBMED
ScienceOn
|
| 3 |
Vanoverschelde JL, Melin JA. The pathophysiology of myocardial hibernation: current controversies and future directions. Prog Cardiovasc Dis 2001;43:387-98
DOI
ScienceOn
|
| 4 |
Samady H, Elefteriades JA, Abbott BG, Mattera JA, McPherson CA, Wackers FJ. Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worse outcome. Circulation 1999;100:1298-304
DOI
PUBMED
ScienceOn
|
| 5 |
Bonow RO, Dilsizian V. Thallium-201 and technetium-99msestamibi for assessing viable myocardium. J Nucl Med 1992;33:815-8
|
| 6 |
Gropler RJ. Methodology governing the assessment of myocardial glucose metabolism by positron emission tomography and fluorine 18-labeled fluorodeoxyglucose. J Nucl Cardiol 1994;1:S4-14
DOI
|
| 7 |
Di Carli MF, Davidson M, Little R, Khanna S, Mody FV, Brunken RC, et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994;73:527-33
DOI
ScienceOn
|
| 8 |
Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coil Cardiol 2002;39:1151-8
DOI
ScienceOn
|
| 9 |
Bax JJ, Patton JA, Poldermans D, Elhendy A, Sandler MP. F-18 Fluorodeoxyglucose imaging with positron emission tomography and single photon emission computed tomography: cardiac applications. Semin Nucl Med 2000;30:281-98
DOI
ScienceOn
|
| 10 |
Knuuti MJ, Yki-Jiirvinen H, Voipio-Pulkki LM, Maki M, Ruotsalainen U, Harkonen R, et al. Enhancement of myocardial [fluorine-18]fluorodeoxyglucose uptake by a nicotinic acid derivative. J Nucl Med 1994;35:989-98
PUBMED
ScienceOn
|
| 11 |
King LM, Opie LH. Glucose delivery is a major determinant of glucose utilisation in the ischemic myocardium with a residual coronary flow. Cardiovasc Res 1998;39:381-92
DOI
ScienceOn
|
| 12 |
RahimtoolaSH. The hibernating myocardium. Am Heart J 1989;117:211-21
DOI
ScienceOn
|
| 13 |
Bax JJ, Poldermans D, Elhendy A, Boersma E, Rahimtoola SH. Sensitivity, specificity, and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium. Curr Probl Cardiol 2001;26:147-86
DOI
ScienceOn
|
| 14 |
Bax JJ, Maddahi J, Poldermans D, Elhendy A, Cornel JH, Boersma E, et al. Sequential ( )Tl imaging and dobutamine echocardiography to enhance accuracy of predicting improved left ventricular ejection fraction after revascularization. J Nucl Med 2002;43:795-802
ScienceOn
|
| 15 |
Schinkel AF, Poldermans D, Vanoverschelde JL, Elhendy A, Boersma E, Roelandt JR, et al. Incidence of recovery of contractile function following revascularization in patients with ischemic left ventricular dysfunction. Am J Cardiol 2004;93:14-7
DOI
ScienceOn
|
| 16 |
Bax JJ, van der Wall EE, Harbinson M. Radionuclide techniques for the assessment of myocardial viability and hibemation. Heart 2004;90(Suppl 5):26-33
DOI
ScienceOn
|
| 17 |
Dilsizian V, Bonow RO. Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation 1993;87:1-20
DOI
PUBMED
ScienceOn
|
| 18 |
Sciagra R, Pellegri M, Pupi A, Bolognese L, Bisi G, Carnovale V, Santoro GM. Prognostic implications of Tc-99m sestamibi viability imaging and subsequent therapeutic strategy in patients with chronic coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 2000;36:739-45
DOI
ScienceOn
|
| 19 |
Marwick TH, Zuchowski C, Lauer MS, Secknus MA, Williams J, Lytle BW. Functional status and quality of life in patients with heart failure undergoing coronary bypass surgery after assessment of myocardial viability. J Am Coll Cardiol 1999;33:750-8
DOI
ScienceOn
|
| 20 |
Maes A, Flameng W, Nuyts J, Borgers M, Shivalkar B, Ausma J, et al. Histological alterations in chronically hypoperfused myocardium. Correlation with PET findings. Circulation 1994;90:735-45
DOI
PUBMED
ScienceOn
|
| 21 |
Maddahi J, Scheibert H, Brunken R, Di Carli M. Role of thallium-201 and PET imaging in evaluation of myocardial viability and management of patients with coronary artery disease and left ventricular dysfunction. J Nucl Med. 1994;35:707-15
PUBMED
ScienceOn
|
webmaster
